IGF1 and type 2 diabetes mellitus: Rare damaging variants in IGFBP3 (the major IGF binding protein), which lowered circulating IGF-1 levels, were nominally associated with taller childhood height (indicative of higher IGF-1 bioactivity) and lower risk of T2D.